BridgeBio Pharma Cash from Financing (Quarterly) Insights

BridgeBio Pharma Inc (BBIO)

25.51 +0.32 (+1.27%) USD | NASDAQ | Nov 05, 15:59

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
June 30, 2024	-5.729M
March 31, 2024	279.55M
December 31, 2023	-4.523M
September 30, 2023	307.04M
June 30, 2023	-1.231M
March 31, 2023	150.25M
December 31, 2022	6.377M
September 30, 2022	1.445M
June 30, 2022	-20.80M
March 31, 2022	-0.16M
December 31, 2021	325.38M
September 30, 2021	-135.46M
June 30, 2021	-1.391M

Date	Value
March 31, 2021	547.91M
December 31, 2020	4.531M
September 30, 2020	2.782M
June 30, 2020	0.703M
March 31, 2020	439.17M
December 31, 2019	42.90M
September 30, 2019	367.51M
June 30, 2019	-9.969M
March 31, 2019	-1.651M
December 31, 2018	274.17M
September 30, 2018	-1.727M
June 30, 2018	213.41M
March 31, 2018	15.69M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-135.46M

Minimum

Sep 2021

547.91M

Maximum

Mar 2021

102.04M

Average

2.782M

Median

Sep 2020

Cash from Financing (Quarterly) Benchmarks

Alnylam Pharmaceuticals Inc	102.76M
Pfizer Inc	-2.459B
Vertex Pharmaceuticals Inc	-358.60M
PTC Therapeutics Inc	246.48M
Bristol-Myers Squibb Co	-3.852B

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	74.70M
Cash from Investing (Quarterly)	3.039M
Free Cash Flow	-419.68M
Free Cash Flow Per Share (Quarterly)	0.3852
Free Cash Flow to Equity (Quarterly)	70.59M
Free Cash Flow Yield	-9.35%